Role of Sp1 and SREBP-1a in the insulin-mediated regulation of glucokinase transcription in the liver of gilthead sea bream (Sparus aurata).

Gen Comp Endocrinol

Departament de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona, Diagonal 643, 08028 Barcelona, Spain.

Published: January 2008

Insulin induction of glucokinase (GCK) transcription in the liver is essential for maintaining glucose homeostasis. To study the molecular mechanism underlying the regulation of hepatic GCK expression in the carnivorous fish gilthead sea bream (Sparus aurata), we analysed the role of sterol regulatory element binding protein-1a (SREBP-1a) and specificity protein (Sp) 1 in insulin-dependent GCK transcription. Transient transfection experiments performed in HepG2 cells and electrophoretic mobility shift assays allowed us to identify a cis-element in the proximal region of GCK promoter implicated in transactivation by SREBP-1a. Consistently, mutations in the SRE binding site completely abolished the enhancing effect of SREBP-1a. These results and previous findings suggest that SREBP-1a plays a role in the transcriptional regulation of key enzymes in glycolysis-gluconeogenesis. Since SREBP-1a and Sp1 may mediate insulin action on S. aurata GCK transcription, we analysed the effect of insulin on HepG2 cells transfected with GCK promoter reporter constructs carrying intact or mutated SRE or Sp boxes. Insulin transactivated GCK irrespective of the presence of an intact or mutated SRE box. However, insulin failed to induce GCK transcription when using reporter constructs that had either a mutated Sp site or no Sp site. Our findings indicate that Sp1, rather than SREBP-1a, mediates the insulin-dependent induction of S. aurata GCK.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygcen.2007.06.018DOI Listing

Publication Analysis

Top Keywords

gck transcription
16
gck
9
sp1 srebp-1a
8
transcription liver
8
gilthead sea
8
sea bream
8
bream sparus
8
sparus aurata
8
hepg2 cells
8
gck promoter
8

Similar Publications

Transcriptome-wide Mendelian randomization during CD4 T cell activation reveals immune-related drug targets for cardiometabolic diseases.

Nat Commun

October 2024

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Article Synopsis
  • The study explores how immune responses can impact drug development for cardiometabolic diseases like type 2 diabetes (T2D) and coronary artery disease (CAD) by examining gene expression during T cell activation.
  • Findings revealed specific genes connected to increased risks of T2D and CAD, with a significant portion showing a particular role tied to CD4 T cells.
  • Additionally, the research identified genes that are potential drug targets currently being investigated, highlighting the importance of immune responses in addressing these diseases.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the link between whole exome sequencing (WES) data and clinical features in children diagnosed with type 1 diabetes before age 5, analyzing 99 unrelated cases.
  • Of the participants, 8.1% had potentially harmful rare variants in MODY genes, which were associated with specific genetic risk factors and different clinical markers compared to those without these variants.
  • The findings suggest that WES may help identify distinct subtypes (endotypes) of type 1 diabetes and pave the way for tailored treatments in young patients.
View Article and Find Full Text PDF

Novel approach for ameliorating high-fat diet-induced syndromes probiotic-fermented oyster mushroom: from metabolites and microbiota to regulation mechanisms.

Food Funct

October 2024

Key Laboratory for Processing and Quality Safety Control of Characteristic Agricultural Products, the Ministry of Agriculture and Rural Affairs, Shihezi University, Shihezi 832003, China.

Article Synopsis
  • This study looked at how fermented oyster mushrooms (FOM) might help reduce fat in the body and improve gut health.
  • The results showed that FOM helped lower fat levels in the liver and improved the way the body processes sugars and fats.
  • FOM also changed the gut bacteria to support good bacteria while reducing bad ones, which could help with obesity.
View Article and Find Full Text PDF

Astrocyte glycogenolysis shapes ventromedial hypothalamic nucleus (VMN) regulation of glucostasis in vivo. Glucose transporter-2 (GLUT2), a plasma membrane glucose sensor, controls hypothalamic primary astrocyte culture glycogen metabolism in vitro. In vivo gene silencing tools and single-cell laser-catapult-microdissection/multiplex qPCR techniques were used here to examine whether GLUT2 governs dorsomedial (VMNdm) and/or ventrolateral (VMNvl) VMN astrocyte metabolic sensor and glycogen metabolic enzyme gene profiles.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!